Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trialJean-Marc Classe, Olivier Gléhen, François Quénet et al.|The Lancet Oncology|2024Cited by 70
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer (CHIPOR): A Randomized, Open-Label, Phase 3 TrialJean-Marc Classe, Olivier Gléhen, Pierre Méeus et al.|Obstetrical & Gynecological Survey|2025Cited by 0